Currently, there are 956.00M common shares owned by the public and among those 932.31M shares have been available to trade.
The company’s stock has a 5-day price change of -7.02% and -6.09% over the past three months. CRM shares are trading -8.51% year to date (YTD), with the 12-month market performance up to 4.16% higher. It has a 12-month low price of $212.00 and touched a high of $369.00 over the same period. CRM has an average intraday trading volume of 6.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.55%, -8.39%, and 5.69% respectively.
Institutional ownership of Salesforce Inc (NYSE: CRM) shares accounts for 82.17% of the company’s 956.00M shares outstanding.
It has a market capitalization of $292.73B and a beta (3y monthly) value of 1.35. The stock’s trailing 12-month PE ratio is 50.32, while the earnings-per-share (ttm) stands at $6.08. The company has a PEG of 3.18 and a Quick Ratio of 1.01 with the debt-to-equity ratio at 0.21. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.73% over the week and 2.81% over the month.
Analysts forecast that Salesforce Inc (CRM) will achieve an EPS of 2.61 for the current quarter, 2.62 for the next quarter and 11.21 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 2.48 while analysts give the company a high EPS estimate of 2.48. Comparatively, EPS for the current quarter was 2.29 a year ago. Earnings per share for the fiscal year are expected to increase by 21.98%, and 11.70% over the next financial year. EPS should shrink at an annualized rate of 15.83% over the next five years, compared to 24.06% over the past 5-year period.
TD Cowen coverage for the Salesforce Inc (CRM) stock in a research note released on January 17, 2025 offered a Buy rating with a price target of $400. Guggenheim was of a view on January 06, 2025 that the stock is Sell, while KeyBanc Capital Markets gave the stock Overweight rating on December 13, 2024, issuing a price target of $440. Macquarie on their part issued Neutral rating on December 12, 2024.
